DelveInsight’s Neurology Devices Market Insights Report 2030 provides the current and forecast market analysis, individual leading Neurology Devices Companies market shares, challenges, Neurology Devices Market Drivers, barriers, trends, and key market Neurology Devices companies in the market.
To read more about the latest highlights related to the Neurology Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/report-store/neurology-devices-market
Key Takeaways from the Neurology Devices Market Report
- In May 2022, the US Food and Drug Administration permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease, marking a significant advancement in neurology diagnostics.
- In November 2021, Insightec received US FDA approval for Exablate Neuro, a new device intended for treating patients with advanced Parkinson’s disease.
- The global Neurology Devices Market is estimated to grow at a CAGR of 7.46% during the forecast period from 2024 to 2030, driven by the increasing prevalence of brain injury, dementia, Alzheimer’s disease, and a rising geriatric population.
- The leading Neurology Devices Companies include Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.
- North America is expected to dominate the Neurology Devices market, driven by the rising prevalence of head injuries, Parkinson’s disease, Alzheimer’s disease, a growing geriatric population, and the presence of key market players in the region.
To know more about why North America is leading the market growth in the Neurology Devices Market, get a snapshot @ Neurology Devices Market Outlook
Neurology Devices Market Dynamics
According to the World Health Organization (WHO) 2022, worldwide around 55 million people were suffering from dementia in 2020, with millions of new cases occurring every year. WHO data also indicates that approximately 8.5 million people had Parkinson’s disease (PD) in 2019, with the condition leading to 5.8 million disability-adjusted life years. The increasing geriatric population is a major contributing factor, as WHO 2021 estimates suggest that by 2030, 1 in 6 people will be aged 60 years or above, with this number reaching around 2.1 billion globally by 2050. As age increases, so does the tendency to suffer from neurological diseases such as dementia and stroke, collectively driving demand for neurology devices throughout the forecast period from 2024 to 2030.
Get a sneak peek at the Neurology Devices Market Dynamics @ Neurology Devices Market Dynamics Analysis
Neurology Devices Market Segmentation Analysis
Neurology Devices Market by Device Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, and Others), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Neurology Devices Companies
Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.
Neurology Devices Market Drivers
The demand for neurology devices is being driven by several key factors, including the rise in the number of regulatory approvals for neurology devices across the globe and the increasing cases of head injuries owing to accidents, workplace injuries, and other causes. The rise in the geriatric population, coupled with the increasing prevalence of neurological diseases such as Alzheimer’s, Parkinson’s, and dementia, is significantly increasing demand for diagnostic and therapeutic neurology solutions. A growing focus on improving the safety, affordability, and usability of neurology devices for end users, along with continuous product launches such as spinal cord stimulation systems for chronic pain management, are creating a supportive environment for sustained market growth. These trends are expected to position the neurology devices market for robust and steady expansion from 2024 to 2030.
Which MedTech key players in the Neurology Devices Market are set to emerge as the trendsetter? Explore @ Neurology Devices Companies
Scope of the Neurology Devices Market Report
- Coverage: Global
- Forecast Period: 2024-2030
- Neurology Devices Companies: Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.
Interested in knowing the Neurology Devices Market by 2030? Click to get a snapshot of the Neurology Devices Market Trends
Table of Contents
- Neurology Devices Market Report Introduction
- Neurology Devices Market Executive Summary
- Regulatory Analysis
- Neurology Devices Market Key Factors Analysis
- Neurology Devices Market Porter’s Five Forces Analysis
- COVID-19 Impact Analysis on Neurology Devices Market
- Neurology Devices Market Layout
- Neurology Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
